A single nucleotide polymorphism in the human H-ras proto-oncogene determines the risk of urinary bladder cancerJOHNE, Andreas; ROOTS, Ivar; BROCKMÖLLER, Jürgen et al.Cancer epidemiology, biomarkers & prevention. 2003, Vol 12, Num 1, pp 68-70, issn 1055-9965, 3 p.Article

Routine Micromethod for the Determination of Vitamin K1 in Human PlasmaMEINEKE, Ingolf; WILLNOW, Cornelia; STINGL, Julia et al.Therapeutic drug monitoring. 2013, Vol 35, Num 6, pp 859-862, issn 0163-4356, 4 p.Article

Improved solid-phase extraction and HPLC measurement of torasemide and its important metabolitesENGELHARDT, Sabine; MEINEKE, Ingolf; BROCKMÖLLER, Jürgen et al.Journal of chromatography. B. 2006, Vol 831, Num 1-2, pp 31-35, issn 1570-0232, 5 p.Article

Association of nat1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with nat1^*10CASCORBI, Ingolf; ROOTS, Ivar; BROCKMÖLLER, Jürgen et al.Cancer research (Baltimore). 2001, Vol 61, Num 13, pp 5051-5056, issn 0008-5472Article

Benzydamine N-oxidation as an index reaction reflecting FMO activity in human liver microsomes and impact of fm03 polymorphisms on enzyme activitySTÖRMER, Elke; ROOTS, Ivar; BROCKMÖLLER, Jürgen et al.British journal of clinical pharmacology. 2000, Vol 50, Num 6, pp 553-561, issn 0306-5251Article

Contributions of CYP2D6, CYP2C9 and CYP2C19 to the biotransformation of E- and Z-doxepin in healthy volunteersKIRCHHEINERA, Julia; MEINEKE, Ingolf; MÜLLER, Gunnar et al.Pharmacogenetics (London). 2002, Vol 12, Num 7, pp 571-580, issn 0960-314X, 10 p.Article

Trimipramine pharmacokinetics after intravenous and oral administration in carriers of CYP2D6 genotypes predicting poor, extensive and ultrahigh activityKIRCHHEINER, Julia; SASSE, Johanna; MEINEKE, Ingolf et al.Pharmacogenetics (London). 2003, Vol 13, Num 12, pp 721-728, issn 0960-314X, 8 p.Article

Atrial natriuretic peptide polymorphisms, hydrochlorothiazide and urinary potassium excretionSTEFAN VIKTOR VORMFELDE; MOHAMMAD REZA TOLIAT; NÜRNBERG, Peter et al.International journal of cardiology. 2010, Vol 144, Num 1, pp 72-74, issn 0167-5273, 3 p.Article

Common genetic variations in human brain-specific tryptophan hydroxylase-2 and response to antidepressant treatmentTZVETKOV, Mladen Vassilev; BROCKMÖLLER, Jürgen; ROOTS, Ivar et al.Pharmacogenetics and genomics (Print). 2008, Vol 18, Num 6, pp 495-506, issn 1744-6872, 12 p.Article

Effect of genetic polymorphisms in cytochrome P450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs : Clinical relevanceKIRCHHEINER, Julia; ROOTS, Ivar; GOLDAMMER, Mark et al.Clinical pharmacokinetics. 2005, Vol 44, Num 12, pp 1209-1225, issn 0312-5963, 17 p.Article

Simultaneous determination of celecoxib, hydroxycelecoxib, and carboxycelecoxib in human plasma using gradient reversed-phase liquid chromatography with ultraviolet absorbance detectionSTÖRMER, Elke; BAUER, Steffen; KIRCHHEINER, Julia et al.Journal of chromatography. B, Biomedical sciences and applications. 2003, Vol 783, Num 1, pp 207-212, issn 1387-2273, 6 p.Article

Can extremely low or high morphine formation from codeine be predicted prior to therapy initiation?LÖTSCH, Jörn; ROHRBACHER, Maren; SCHMIDT, Helmut et al.Pain (Amsterdam). 2009, Vol 144, Num 1-2, pp 119-124, issn 0304-3959, 6 p.Article

Influx and efflux transport as determinants of melphalan cytotoxicity: Resistance to melphalan in MDR1 overexpressing tumor cell linesKÜHNE, Annett; VASSILEV TZVETKOV, Mladen; HAGOS, Yohannes et al.Biochemical pharmacology. 2009, Vol 78, Num 1, pp 45-53, issn 0006-2952, 9 p.Article

Influence of CYP2C9 genetic polymorphisms on pharmacokinetics of celecoxib and its metabolitesKIRCHHEINER, Julia; STÖRMER, Elke; MEISEL, Christian et al.Pharmacogenetics (London). 2003, Vol 13, Num 8, pp 473-480, issn 0960-314X, 8 p.Article

Pharmacokinetics of diclofenac and inhibition of cyclooxygenases 1 and 2: no relationship to the CYP2C9 genetic polymorphism in humansKIRCHHEINER, Julia; MEINEKE, Ingolf; STEINBACH, Nadine et al.British journal of clinical pharmacology. 2003, Vol 55, Num 1, pp 51-61, issn 0306-5251, 11 p.Article

Enantiospecific effects of cytochrome P450 2C9 amino acid variants on ibuprofen pharmacokinetics and on the inhibition of cyclooxygenases 1 and 2KIRCHHEINER, Julia; MEINEKE, Ingolf; FREYTAG, Georg et al.Clinical pharmacology and therapeutics. 2002, Vol 72, Num 1, pp 62-75, issn 0009-9236Article

Impact of CΥP2C9 amino acid polymorphisms on glyburide lunatics and on the insulin and glucose response in healthy volunteersKIRCHHEINER, Julia; BROCKMÖLLER, Jürgen; MEINEKE, Ingolf et al.Clinical pharmacology and therapeutics. 2002, Vol 71, Num 4, pp 286-296, issn 0009-9236Article

Effects of the CYP2D6 Gene Duplication on the Pharmacokinetics and Pharmacodynamics of TramadolKIRCHHEINER, Julia; KEULEN, Jan-Tobias H. A; BAUER, Steffen et al.Journal of clinical psychopharmacology. 2008, Vol 28, Num 1, pp 78-83, issn 0271-0749, 6 p.Article

Torasemide Transport by Organic Anion Transporters Contributes to HyperuricemiaHAGOS, Yohannes; BAHN, Andrew; VORMFELDE, Stefan V et al.Journal of the American Society of Nephrology. 2007, Vol 18, Num 12, pp 3101-3109, issn 1046-6673, 9 p.Article

Impact of the CYP2D6 ultrarapid metabolizer genotype on mirtazapine pharmacokinetics and adverse events in healthy volunteersKIRCHHEINER, Julia; HENCKEL, Hanns-Benjamin; MEINEKE, Ingolf et al.Journal of clinical psychopharmacology. 2004, Vol 24, Num 6, pp 647-652, issn 0271-0749, 6 p.Article

Effects of polymorphisms in CYP2D6, CYP2C9, and CYP2C19 on trimipramine pharmacokineticsKIRCHHEINER, Julia; MÜLLER, Gunnar; MEINEKE, Ingolf et al.Journal of clinical psychopharmacology. 2003, Vol 23, Num 5, pp 459-466, issn 0271-0749, 8 p.Article

Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: Insights into the measurement of hepatic cytochrome P450 1A2 inductionABRAHAM, Klaus; GEUSAU, Alexandra; TOSUN, Yalcin et al.Clinical pharmacology and therapeutics. 2002, Vol 72, Num 2, pp 163-174, issn 0009-9236Article

Differential effects of Saint John's Wort (hypericum perforatum) on the urinary excretion of D-glucaric acid and 6β-hydroxycortisol in healthy volunteersBAUER, Steffen; STÖRMER, Elke; KERB, Reinhold et al.European journal of clinical pharmacology. 2002, Vol 58, Num 9, pp 581-585, issn 0031-6970, 5 p.Article

A Functional Polymorphism in the NAD(P)H Oxidase Subunit CYBA Is Related to Gene Expression, Enzyme Activity, and Outcome in Non-Hodgkin LymphomaHOFFMANN, Marion; SCHIRMER, Markus A; BROCKMÖLLER, Jürgen et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 6, pp 2328-2338, issn 0008-5472, 11 p.Article

AmpliChip CYP450 GeneChip® : A new gene chip that allows rapid and accurate CYP2D6 genotypingHELLER, Tanja; KIRCHHEINER, Julia; ARMSTRONG, Victor W et al.Therapeutic drug monitoring. 2006, Vol 28, Num 5, pp 673-677, issn 0163-4356, 5 p.Article